Abstract:ABSTRACT The liver has a remarkable capacity to regenerate and thus compensates for repeated injuries through toxic chemicals, drugs, alcohol or malnutrition for decades. However, largely unknown is how and when alterations in the liver occur due to tolerable damaging insults. To that end, we induced repeated liver injuries over ten weeks in a mouse model injecting carbon tetrachloride (CCl 4 ) twice a week. We lost 10% of the study animals within the first six weeks, which was accompanied by a steady deposition of extracellular matrix (ECM) regardless of metabolic activity of the liver. From week six onwards, all mice survived, and in these mice ECM deposition was rather reduced, suggesting ECM remodeling as a liver response contributing to better coping with repeated injuries. The data of time-resolved paired transcriptome and proteome profiling of 18 mice was subjected to multi-level network inference, using Knowledge guided Multi-Omics Network inference (KiMONo), identified multi-level key markers exclusively associated with the injury-tolerant liver response. Interestingly, pathways of cancer and inflammation were lighting up and were validated using independent data sets compiled of 1034 samples from publicly available human cohorts. A yet undescribed link to lipid metabolism in this damage-tolerant phase was identified. Immunostaining revealed an unexpected accumulation of small lipid droplets (microvesicular steatosis) in parallel to a recovery of catabolic processes of the liver to pre-injury levels. Further, mild inflammation was experimentally validated. Taken together, we identified week six as a critical time point to switch the liver response program from an acute response that fosters ECM accumulation to a tolerant “survival” phase with pronounced deposition of small lipid droplets in hepatocytes potentially protecting against the repetitive injury with toxic chemicals. Our data suggest that microsteatosis formation plus a mild inflammatory state represent biomarkers and probably functional liver requirements to resist chronic damage. Graphical abstract The datasets generated via transcriptomics, proteomics as well as blood, histopathological and biochemical analysis were analyzed in an independent and integrative manner. The independent analysis was performed via state-of-the-art statistical approaches i.e. differential and consistently regulated genes and proteins. Combining the results identified three fibrosis phases. Using the KiMONo algorithm, a fibrosis specific multi-omic network was inferred. Within this network we identified several nodes connecting phase III specific features forming 13 distinct multi-omic modules suggesting a tolerance scheme. Some of these modules were experimentally validated and compared to 11 independent human studies of various liver diseases.

Development of a hepatic cryoinjury model to study liver regeneration

Development of a hepatic cryoinjury model to study liver regeneration

Repeated Toxic Injuries of Murine Liver Are Tolerated Through Microsteatosis and Mild Inflammation

Multimodal decoding of human liver regeneration

Cell atlas of the regenerating human liver after portal vein embolization

Liver Injury and Regeneration: Current Understanding, New Approaches, and Future Perspectives

Liver regeneration after injury: Mechanisms, cellular interactions and therapeutic innovations

Liver fibrosis and repair: immune regulation of wound healing in a solid organ

Advances in the regulation of liver regeneration

A narrative review of liver regeneration—from models to molecular basis

MicroRNAs in Liver Regeneration

Liver regeneration and inflammation: from fundamental science to clinical applications

Acquisition of epithelial plasticity in human chronic liver disease

Region-specific cellular and molecular basis of liver regeneration after acute pericentral injury

LiverZap: a chemoptogenetic tool for global and locally restricted hepatocyte ablation to study cellular behaviours in liver regeneration

Liver Regeneration in Chronic Liver Injuries: Basic and Clinical Applications Focusing on Macrophages and Natural Killer Cells

Divergent Angiocrine Signals from Vascular Niche Balance Liver Regeneration and Fibrosis

Liver regeneration: Cellular origin and molecular mechanisms

Utilising an in silico model to predict outcomes in senescence-driven acute liver injury

Role of hepatic resident and infiltrating macrophages in liver repair after acute injury

Platelets Prime Hematopoietic–vascular Niche to Drive Angiocrine-Mediated Liver Regeneration